News Express: Joint symposium on cancer biology held at UM

新聞快訊:癌症生物學聯合研討會在澳大舉辦

 

癌症生物學聯合研討會在澳大舉辦
The joint symposium on cancer biology is held at UM

 

 
癌症生物學聯合研討會在澳大舉辦

“國家教育部澳門大學精準腫瘤學前沿科學中心、深圳理工大學合成生物學院及中國科學院深圳先進技術研究院合成生物學研究所聯合研討會”在澳大舉行,吸引超過100位生物醫學領域的專家學者及研究人員參與,共同探討癌症生物學的最新研究進展。
 
研討會由澳門大學健康科學學院、國家教育部澳門大學精準腫瘤學前沿科學中心、深圳理工大學合成生物學院、中國科學院深圳先進技術研究院合成生物學研究所合辦。開幕儀式上,澳門大學健康科學學院院長兼國家教育部精準腫瘤學前沿科學中心首席科學家鄧初夏指出,澳大健康科學學院自成立以來,在精準腫瘤研究方面取得顯著成果,相關研究成效獲國際學界廣泛認可;並成功獲批設立港澳地區首個、唯一的國家級前沿科學中心,標誌著澳門在醫學科研領域邁向新高度。他亦期望中心主導的研究能為澳門及區域醫學發展奠定堅實基礎。
 
深圳理工大學合成生物學院院長張先恩則在致辭中闡述中國合成生物學的戰略方向,並強調深圳市政府對該領域的大力支持,尤其是在深圳理工大學及中國科學院深圳先進技術研究院的推動下,合成生物學在癌症治療中展現多元應用潛力。他指出,澳大健康科學學院及深圳理工合成生物學院在科研重點及科學基礎方面高度契合,共同舉辦是次研討會為雙方提供了寶貴平台,促進知識交流與合作。
 
研討會旨在探討精準腫瘤學和癌症生物學領域的研究前沿,包括免疫治療、癌症機制、癌症幹細胞、抗癌藥物新材料等方面的最新進展、成果轉化和挑戰,並探討尋找對抗癌症的新技術和新理論的策略。研討會共邀請11位頂尖科學家作精彩演講,包括鄧初夏、澳大健康科學學院助理院長狄利俊及張宣軍、副教授代云路、助理教授苗凱,深圳理工合成生物學院講席教授趙勇、教授連祺周,深圳先進院合成生物學研究所研究員魏平、胡政、甘海雲和王宇。研討會期間,與會者積極參與問答和討論環節,促進學術交流。
 
是次研討會為國家教育部澳門大學精準腫瘤學前沿科學中心繼2024年與同濟大學及北京大學合作後舉辦的第三次聯合研討會。該系列研討會為參與機構的癌症研究專家提供了寶貴平台,深化前沿科研成果探討,推動跨學科創新合作,助力醫學科技發展。
 

 
Joint symposium on cancer biology held at UM

The ‘MoE-FSCPO/SUAT Joint Workshop/Symposium on Cancer Biology’ was held at the University of Macau (UM). The event brought together over 100 experts, scholars, and researchers in biomedical sciences to discuss the latest research advances in cancer biology.

The symposium was jointly organised by the Faculty of Health Sciences (FHS) of UM, the Ministry of Education Frontiers Science Center for Precision Oncology, University of Macau (FSCPO), the Faculty of Synthetic Biology of Shenzhen University of Advanced Technology (SUAT), and the Institute of Synthetic Biology of the Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences (SIAT). Speaking at the opening ceremony, Chuxia Deng, dean of FHS and chief scientist of FSCPO, highlighted FHS’s significant progress in precision oncology research following its establishment, adding that the faculty’s research outcomes have been recognised by the international academic community. He noted that the establishment of FSCPO, the first and only national-level frontiers science centre in Hong Kong and Macao, represents a new milestone for Macao’s advancements in medical research. Deng also expressed hope that research projects led by FSCPO will lay a solid foundation for future medical development in Macao and the wider region.

In his speech, Zhang Xian-En, dean of the Faculty of Synthetic Biology at SUAT, outlined China’s strategic direction in synthetic biology. He highlighted the strong support from the Shenzhen Municipal Government for the field, and noted that the collaborative efforts of SUAT and SIAT have yielded promising applications of synthetic biology in cancer treatment. He also mentioned that the Faculty of Health Sciences of UM and the Faculty of Synthetic Biology of SUAT have a strong alignment of their research focus and basic research, and that the joint symposium would provide a platform for promoting knowledge exchange and collaboration between the two parties.

The aim of the joint symposium was to explore cutting-edge research in precision oncology and cancer biology. These included the latest developments, translations, and challenges in immunotherapy, cancer mechanisms, cancer stem cells, and new materials for cancer drugs. Strategies to identify new technologies and theories to combat cancer were also discussed. The joint symposium featured 11 inspiring presentations by leading scientists from UM, SUAT, and SIAT. They included: Chuxia Deng; Di Lijun and Zhang Xuanjun, assistant deans of FHS; Dai Yunlu, associate professor in FHS; and Miao Kai, assistant professor in FHS; Zhao Yong, chair professor in the Faculty of Synthetic Biology at SUAT; Lian Qizhou, professor in the Faculty of Synthetic Biology at SUAT; Wei Ping, Hu Zheng, Gan Haiyun, Wang Yu, researchers in the Institute of Synthetic Biology at SIAT. Attendees actively engaged in the Q&A and discussion sessions during the symposium, fostering academic exchange.

This is the third joint symposium organised by FSCPO. The centre previously held two joint symposia in 2024, in partnership with Tongji University and Peking University, respectively. These symposia have provided a valuable platform for cancer research experts from the participating institutions to engage in in-depth discussions on their cutting-edge research findings, foster interdisciplinary and innovative research collaboration, and contribute to technological advancements in medical science.

To read the news on UM’s official website, please visit the following link:
https://www.um.edu.mo/news-and-press-releases/press-release/detail/61465/